Generic Name and Formulations:
Olopatadine HCl 0.2%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for PATADAY:
Treatment of ocular itching associated with allergic conjunctivitis.
Adults and Children:
<3yrs: not recommended. ≥3yrs: 1 drop in each affected eye once daily.
Contact lenses (remove; may reinsert 10 minutes after administration, if eye is not red). Pregnancy (Cat.C). Nursing mothers.
Cold syndrome, pharyngitis, ocular effects (eg, blurred vision, burning/stinging, dry eye, foreign body sensation, hyperemia, keratitis, lid edema, pruritus), headache, asthenia, rhinitis, sinusitis, taste perversion.
Endocrinology Advisor Articles
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- Effect of Growth Hormone Treatment on BMD in Adults With Prader-Willi Syndrome
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women
- Use of FSH in Early Diagnosis of Turner Syndrome
- Surgical Treatment Better Than Medical Therapy in Severely Obese Adolescents With T2D
- Metformin May Improve Pregnancy Outcomes in Polycystic Ovary Syndrome